- Potentially effective as add-on therapy in the long-term management of patients with bipolar disorder.
- Potentially effective as add-on therapy to promote weight loss.
GSK counterclaims
- There are no controlled data to support the use of topiramate.
- Numerous failed/negative bipolar studies have been conducted by the sponsor (Janssen).
- Topiramate is not registered for use in bipolar disorder.